Welcome to our dedicated page for Iperionx SEC filings (Ticker: IPX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
IperionX Limited filings document foreign private issuer reports, operating updates, governance actions, and market disclosures for a Nasdaq and ASX-listed titanium technology company. Form 6-K exhibits include quarterly reports on titanium powder production and component manufacturing, shareholder letters, investor presentations, meeting materials, ASX correspondence, and notices of company secretary and registered-office changes.
The filings describe the company’s HAMR™ and HSPT™ technologies, Virginia Titanium Manufacturing Campus, Titan critical minerals project, U.S. Department of War grant programs, reimbursement mechanics, equipment procurement treatment, and customer-related manufacturing activity. Governance and ownership disclosures cover shareholder meeting results, equity incentive approvals, director and officer ownership changes, and communications between the company and ASX.
IPERIONX Ltd director Hannigan Todd made an open-market purchase of 225,225 Ordinary Shares at $3.2009 per share. After this transaction, he directly holds 25,628,334 Ordinary Shares.
He also holds performance rights over 306,302 underlying Ordinary Shares at each of A$6, A$7 and A$8 exercise prices, plus 454,464 Restricted Stock Units and 50,000 American Depository Shares, where each ADS is convertible into 10 Ordinary Shares.
IPERIONX Ltd Chief Executive Officer Arima Anastasios reported significant open-market share purchases. On March 27, 2026, he bought 467,000 Ordinary Shares at an average price of A$3.198, taking his direct Ordinary Share holdings to 12,206,782.
On the same date, he also bought 12,800 American Depository Shares (ADS) at an average price of $23.4097, and now holds 12,800 ADS directly. Each ADS represents 10 Ordinary Shares.
He also holds Performance Rights over 435,806 underlying Ordinary Shares at each of A$6, A$7, and A$8, all expiring on April 10, 2030, plus 738,576 Restricted Stock Units, with 318,666 vesting in December 2026 and 419,910 in April 2028.
IPERIONX Ltd President Toby Symonds has filed an initial ownership report detailing his equity and incentive holdings. He directly holds 3,128,089 Ordinary Shares traded on the ASX and 23,000 American Depository Shares listed on NASDAQ, with each ADS representing 10 ordinary shares.
He also holds 703,199 Restricted Stock Units, with 302,666 vesting in December 2026 and 400,533 vesting in April 2028. In addition, he has Performance Rights over 1,110,000 underlying Ordinary Shares at A$4 expiring on December 21, 2028, and 415,695 underlying shares at each of A$6, A$7, and A$8 exercise prices, all expiring on April 10, 2029.
IPERIONX Ltd director Hannigan Todd has filed an initial Form 3 reporting his existing equity interests in the company. The filing lists direct ownership of 25,403,109 Ordinary Shares, 454,464 Restricted Stock Units, and 50,000 American Depository Shares, each ADS representing ten Ordinary Shares traded on NASDAQ.
He also holds performance rights over 306,302 underlying IPX Ordinary Shares at each of A$6, A$7, and A$8 exercise prices, expiring in April 2030. Footnotes state that 159,334 units vest in December 2026 and 295,130 vest in April 2028, highlighting a structured, long-term incentive position rather than new market transactions.
IPERIONX Ltd Chief Executive Officer Anastasios Arima reports his existing equity stake in the company. He directly holds 11,739,782 Ordinary Shares, which trade on the Australian Securities Exchange. He also holds 738,576 Restricted Stock Units, with portions vesting in December 2026 and April 2028.
In addition, Arima holds three tranches of performance rights over IPX Ordinary Shares, each covering 435,806 underlying shares with exercise prices of A$6, A$7, and A$8. These performance rights are exercisable from April 2029 and expire in April 2030, providing potential future share issuance tied to performance conditions.
IperionX Limited held a General Meeting on March 19, 2026, where shareholders approved four resolutions granting long-term equity incentives to founder executives Anastasios Arima (CEO) and Todd Hannigan (Executive Chair). All resolutions were carried by poll, with support ranging from about 82% to 95% of votes cast.
Shareholders approved up to 1,203,964 Options and 237,944 Performance Rights for Mr. Arima, and up to 992,170 Options and 196,086 Performance Rights for Mr. Hannigan. Option strike prices of A$18 and A$22 and a Performance Rights hurdle of a 30‑day VWAP of A$18 sit well above the A$6.76 share price on February 2, 2026, so value only arises if the share price increases substantially.
The company explains that executive pay is benchmarked to U.S. peers, reflecting its U.S.-based titanium technology and manufacturing focus. The awards have four‑year service requirements, five‑year terms, and, for Performance Rights, an additional one‑year lock‑up, aiming to link executive rewards to long-term shareholder value creation.
IPERIONX Ltd director Taylor Vaughn William has filed an initial ownership report showing direct holdings of 973,457 Ordinary Shares and 84,771 Restricted Stock Units. Footnotes state that 70,609 RSUs vest in December 2026 and 14,162 vest in December 2027, and that Ordinary Shares trade on the ASX.
IPERIONX Ltd director reports initial holdings in a Form 3 filing. Director R Tony Tripeny discloses beneficial ownership of 38,777 Ordinary Shares and 51,010 Restricted Stock Units. The Ordinary Shares trade on the Australian Stock Exchange. Of the RSUs, 36,848 vest in December 2026 and 14,162 vest in December 2027.
IPERIONX Ltd director Melissa Gowdy Waller filed an initial ownership report showing she holds 486,318 Ordinary Shares and 84,771 Restricted Stock Units of the company. According to the filing, 70,609 of these RSUs vest in December 2026 and 14,162 vest in December 2027.
IPERIONX Ltd Chief Financial Officer Marcela Rocha Castro filed an initial statement of beneficial ownership. She directly holds 380,841 IPX ordinary shares and 162,001 restricted stock units, with 79,666 scheduled to vest in December 2026 and 82,335 in December 2028. She also holds options over 216,672 IPX ordinary shares at a conversion price of A$5.00 per share, expiring in April 2029. IPX ordinary shares trade on the Australian Stock Exchange.